期刊
PEDIATRIC INFECTIOUS DISEASE JOURNAL
卷 41, 期 5, 页码 420-423出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/INF.0000000000003478
关键词
HIV1; perinatal transmission; anemia; nevirapine; zidovudine
资金
- National Agency for Research on HIV/AIDS and Hepatitis
- French National Agency for AIDS Research (ANRS)
- ViiV Healthcare
- Bristol-Myers Squibb
- Janssen Cilag
- Gilead Sciences
- MSD France
In the ANRS French Perinatal Cohort, it was found that nevirapine (NVP) had a lower frequency of anemia grade >= 2 compared to zidovudine (AZT) in infants at low risk of HIV acquisition.
In the ANRS French Perinatal Cohort, we compared outcomes in 830 HIV1-exposed infants who received either nevirapine (NVP) or zidovudine postnatal prophylaxis. At 1 month, anemia grade >= 2 was less frequent on NVP than zidovudine (2.9% vs. 8.0%; P = 0.01), favoring the use of NVP as a first choice prophylaxis in infants at low risk of HIV acquisition.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据